Latest filing published 17 Nov 2025 for LAVA Therapeutics NV.
Filing timeline
BuySaleInsider track record
Karen J. Wilson: trading record in brief
Karen J. Wilson has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Jazz Pharmaceuticals plc, Elicio Therapeutics, Inc. and LAVA Therapeutics NV. The record holds 73 filings, for trades running from 7 May 2009 to 13 November 2025.
Sales make up the whole of the open-market record (23 sales, €9.5M). The rest of the record consists of 30 share grants and 16 option exercises.
The record was last updated on 17 November 2025 with a transaction in LAVA Therapeutics NV. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karen J. Wilson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 sharesCommon SharesSEC:0001267490-25-000006:0
- 18,718 shares@ US$11.57100.0% of flowCommon StockSEC:0001567619-21-003192:0
- 276 shares@ US$135.822.9% of flowOrdinary SharesSEC:0001765581-19-000039:0
- 302 shares@ US$135.823.2% of flowOrdinary SharesSEC:0001765581-19-000039:1
- 3,500 shares0Ordinary SharesSEC:0001765581-19-000027:0
- 310 shares@ US$126.253.0% of flowOrdinary SharesSEC:0001765581-19-000010:0
- 230 shares@ US$127.762.3% of flowOrdinary SharesSEC:0001765581-19-000010:1
- 3,706 shares@ US$165.009.5% of flowOrdinary SharesSEC:0001232524-18-000103:0
- 54 shares@ US$165.010.1% of flowOrdinary SharesSEC:0001232524-18-000103:1
- 3,899 shares@ US$155.009.1% of flowOrdinary SharesSEC:0001232524-18-000076:0
- 302 shares@ US$143.390.7% of flowOrdinary SharesSEC:0001232524-18-000060:0
- 3,200 shares0Ordinary SharesSEC:0001232524-18-000049:0
- 537 shares@ US$147.441.2% of flowOrdinary SharesSEC:0001232524-18-000030:0
- 324 shares@ US$143.800.7% of flowOrdinary SharesSEC:0001232524-18-000030:1
- 1,275 shares@ US$160.003.5% of flowOrdinary SharesSEC:0001232524-17-000087:0
- 4,750 shares@ US$59.134.9% of flowOrdinary SharesSEC:0001232524-17-000082:0
- 4,750 shares@ US$152.2412.7% of flowOrdinary SharesSEC:0001232524-17-000082:1
- 6,708 shares@ US$152.2417.9% of flowOrdinary SharesSEC:0001232524-17-000082:3
- 6,708 shares@ US$46.835.5% of flowOrdinary SharesSEC:0001232524-17-000082:2
- 563 shares@ US$132.811.3% of flowOrdinary SharesSEC:0001232524-17-000076:0
- 2,896 shares@ US$46.832.4% of flowOrdinary SharesSEC:0001232524-17-000076:1
- 750 shares@ US$59.130.8% of flowOrdinary SharesSEC:0001232524-17-000076:2
- 3,500 shares0Ordinary SharesSEC:0001232524-17-000063:0
- 935 shares@ US$136.972.3% of flowOrdinary SharesSEC:0001232524-17-000038:0
- 1,467 shares@ US$150.013.7% of flowOrdinary SharesSEC:0001232524-16-000314:0
25 of 73 declarations